De novo-designed transmembrane proteins bind and regulate a cytokine receptor

被引:2
|
作者
Mravic, Marco [1 ,2 ]
He, Li [3 ]
Kratochvil, Huong T. [1 ,4 ]
Hu, Hailin [1 ,5 ]
Nick, Sarah E. [1 ]
Bai, Weiya [3 ]
Edwards, Anne [3 ]
Jo, Hyunil [1 ]
Wu, Yibing [1 ]
Dimaio, Daniel [3 ,6 ,7 ,8 ]
Degrado, William F. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94143 USA
[2] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
[3] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA
[4] Univ N Carolina, Dept Chem, Chapel Hill, NC USA
[5] Tsinghua Univ, Sch Med, Beijing, Peoples R China
[6] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[7] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA
[8] Yale Canc Ctr, New Haven, CT 06510 USA
基金
美国国家卫生研究院;
关键词
ERYTHROPOIETIN RECEPTOR; EPO RECEPTOR; STRUCTURE PREDICTION; TYROSINE KINASE; DOMAIN; DIMERIZATION; ASSOCIATION; PACKING; MOTIFS; MODEL;
D O I
10.1038/s41589-024-01562-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transmembrane (TM) domains as simple as a single span can perform complex biological functions using entirely lipid-embedded chemical features. Computational design has the potential to generate custom tool molecules directly targeting membrane proteins at their functional TM regions. Thus far, designed TM domain-targeting agents have been limited to mimicking the binding modes and motifs of natural TM interaction partners. Here, we demonstrate the design of de novo TM proteins targeting the erythropoietin receptor (EpoR) TM domain in a custom binding topology competitive with receptor homodimerization. The TM proteins expressed in mammalian cells complex with EpoR and inhibit erythropoietin-induced cell proliferation. In vitro, the synthetic TM domain complex outcompetes EpoR homodimerization. Structural characterization reveals that the complex involves the intended amino acids and agrees with our designed molecular model of antiparallel TM helices at 1:1 stoichiometry. Thus, membrane protein TM regions can now be targeted in custom-designed topologies. The study demonstrates that specific recognition and custom binding geometries can be computationally encoded between protein spans within lipids through designing synthetic transmembrane proteins to functionally regulate a target cytokine receptor.
引用
收藏
页码:751 / 760
页数:10
相关论文
共 50 条
  • [1] De novo-designed transmembrane domains tune engineered receptor functions
    Elazar, Assaf
    Chandler, Nicholas J.
    Davey, Ashleigh S.
    Weinstein, Jonathan Y.
    Nguyen, Julie, V
    Trenker, Raphael
    Cross, Ryan S.
    Jenkins, Misty R.
    Call, Melissa J.
    Call, Matthew E.
    Fleishman, Sarel J.
    ELIFE, 2022, 11
  • [2] De Novo-Designed β-Sheet Heme Proteins
    D'Souza, Areetha
    Bhattacharjya, Surajit
    BIOCHEMISTRY, 2021, 60 (06) : 431 - 439
  • [3] Histidine placement in de novo-designed heme proteins
    Gibney, BR
    Dutton, PL
    PROTEIN SCIENCE, 1999, 8 (09) : 1888 - 1898
  • [4] Rational Construction of Compact de Novo-Designed BiliverdinBinding Proteins
    Sheehan, Molly M.
    Magaraci, Michael S.
    Kuznetsov, Ivan A.
    Mancini, Joshua A.
    Kodali, Goutham
    Moser, Christopher C.
    Dutton, P. Leslie
    Chow, Brian Y.
    BIOCHEMISTRY, 2018, 57 (49) : 6752 - 6756
  • [5] Atomic molecular dynamics simulation advances of de novo-designed proteins
    Wang, Moye
    Ma, Anqi
    Wang, Hongjiang
    Lou, Xiaotong
    QUARTERLY REVIEWS OF BIOPHYSICS, 2024, 57
  • [6] On the failure of de novo-designed peptides as biocatalysts
    Corey, MJ
    Corey, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) : 11428 - 11434
  • [7] Carbohydrates as templates for control of distance-geometry in de novo-designed proteins
    K.J. Jensen
    J. Brask
    Cellular and Molecular Life Sciences, 2002, 59 : 859 - 869
  • [8] Carbohydrates as templates for control of distance-geometry in de novo-designed proteins
    Jensen, KJ
    Brask, J
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (05) : 859 - 869
  • [9] On the failure of de novo-designed peptides as biocatalysts
    Proc Natl Acad Sci USA, 21 (11428):
  • [10] The first de novo-designed antagonists of the human NK2 receptor
    Ali, MA
    Bhogal, N
    Findlay, JBC
    Fishwick, CWG
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5655 - 5658